Key result
Hydrophobic 5-hydroxyindole derivatives induce abnormal high-order oligomerization of the MERS-CoV nucleocapsid protein.
Why the study?
Drug development against coronaviruses is inherently arduous, and targeting the nucleocapsid protein's oligomerization and RNA binding offers a potential therapeutic avenue.
Targeting an allosteric site on the CoV nucleocapsid protein with 5-hydroxyindole derivatives induces abnormal aggregation, offering a novel concept for protein-protein interaction-based drug design against coronaviruses.
Answers are grounded in this paper and cite their sources.
Premature for clinical use; leaves open nucleocapsid-targeted antivirals for coronaviruses.
Epidemics caused by coronaviruses (CoVs), namely the severe acute respiratory syndrome (SARS) (2003), Middle East respiratory syndrome (MERS) (2012), and coronavirus disease 2019 (COVID-19) (2019), have triggered a global public health emergency. Drug development against CoVs is inherently arduous. The nucleocapsid (N) protein forms an oligomer and facilitates binding with the viral RNA genome, which is critical in the life cycle of the virus. In the current study, we found a potential allosteric site (Site 1) using PARS, an online allosteric site predictor, in the CoV N-N-terminal RNA-binding domain (NTD) to modulate the N protein conformation. We identified 5-hydroxyindole as the lead via molecular docking to target Site 1. We designed and synthesized four 5-hydroxyindole derivatives, named P4-1 to P4-4, based on the pose of 5-hydroxyindole in the docking model complex. Small-angle X-ray scattering (SAXS) data indicate that two 5-hydroxyindole compounds with higher hydrophobic R-groups mediate the binding between N-NTD and N-C-terminal dimerization domain (CTD) and elicit high-order oligomerization of the whole N protein. Furthermore, the crystal structures suggested that these two compounds act on this novel cavity and create a flat surface with higher hydrophobicity, which may mediate the interaction between N-NTD and N-CTD. Taken together, we discovered an allosteric binding pocket targeting small molecules that induces abnormal aggregation of the CoV N protein. These novel concepts will facilitate protein-protein interaction (PPI)-based drug design against various CoVs.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2022) studied Coronavirus (MERS-CoV, SARS-CoV-2). 5-hydroxyindole derivatives (P4-1 to P4-4) was evaluated on Protein oligomerization and structural conformation. 5-hydroxyindole derivatives with higher hydrophobic R-groups bind to the N-terminal domain of the MERS-CoV nucleocapsid protein and induce its abnormal high-order oligomerization.
Synapse has enriched 10 related papers. Consider them for comparative context: